Extracellular Matrix Alteration
9
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Transcriptomic Analysis of Incisional Hernia Based on High-throughput Sequencing Technology
The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
MMP-9, TIMP-9 in Lung Imaging and Functional of COVID-19
Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma
Influence of Statins in Artery Aneurysms
Matrix Metalloproteinases in Patients With Critical Limb Ischemia Undergoing Surgical Revascularization
Biomarkers in Post Thrombotic Syndrome
Hemorrhoids and Metalloproteinases, Observational Study
Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug Procedure for Anal Fistula Repair